Medicines for Psoriatic Arthritis: A Review of the Research for Adults - Consumer Summary | AHRQ Effective Health Care Program
Consumer Summary – Nov. 20, 2012
Medicines for Psoriatic Arthritis: A Review of the Research for Adults
Formats
- View PDF (PDF) 546 kB
- Help with Viewers, Players, and Plug-ins
Table of Contents
- Is This Information Right for Me?
- Understanding Your Condition
- Understanding DMARDs
- Making a Decision
- Source
Is This Information Right for Me?
Yes, this information is right for you if:
- Your doctor* has told you that you have psoriatic (pronounced sore-ee-AH-tic) arthritis (PsA).
- This is a type of arthritis that affects people with psoriasis (pronounced sore-EYE-ah-sis).
- Psoriasis is an ongoing skin condition that causes red, scaly patches on your body.
- Your doctor has suggested that you take one or more of the following disease-modifying anti-rheumatic drugs (DMARDs, pronounced DEE-mardz)† to help treat your PsA.
- Adalimumab (Humira®)
- Etanercept (Enbrel®)
- Golimumab (Simponi®)
- Infliximab (Remicade®)
- Leflunomide (Arava®)
- Methotrexate (Folex®, Rheumatrex®, Trexall®)
- Sulfasalazine (Azulfidine EN-Tabs®, Sulfazine®)
- You want to know what research says about how well these medicines work to treat PsA.
† There are other DMARDs than those listed here. The DMARDs listed here are the ones studied in the research for this summary.
EHC Component
- EPC Project
Full Report
- Research Review Jun. 1, 2012
Related Products for this Topic
- Research Protocol Dec. 6, 2010
- Clinician Summary Nov. 20, 2012
- Executive Summary (Update) Apr. 24, 2012
Related Topics
Related Links for this Topic
For free print copies of this summary, call 800-358-9295. Ask the Publications Clearinghouse for AHRQ Publication 12(13)-EHC024-A
No hay comentarios:
Publicar un comentario